Breztri Aerosphere Now Available in the US for Asthma
AstraZeneca's triple-combination asthma therapy Breztri Aerosphere was approved in April 2026 for adults and pediatric patients age 12 and older.
Category: Products & Treatment
Products & Treatment
Latest
Products & Treatment
Latest
FDA Authorizes Syncron-E Software for Patient-Ventilator Asynchrony
Autonomous Healthcare received FDA De Novo marketing authorization for Syncron-E, a software that supports the assessment of patient-ventilator asynchrony by detecting evidence of ineffective efforts.
Products & Treatment
Latest
Capnography and Pulse Oximetry in the PICU
For patients in the pediatric ICU, pulse oximetry and waveform capnography are valuable tools to monitor the effectiveness of respiratory support and to inform treatment decisions.
Industry & Regulatory News
Latest
7 Pharma Companies Chosen for FDA PreCheck Pilot Program
The FDA's PreCheck Pilot Program will expand domestic pharmaceutical manufacturing, increase production capacity, and strengthen US drug supply chain resilience.
Pharmaceuticals
Latest
RSV Antiviral Zelicapavir Enters Late-stage Clinical Trials
Enanta Pharma advanced zelicapavir into a registrational Phase 2b/3 clinical trial for adults at high risk of severe RSV outcomes.
Diagnostics & Testing
Latest
Cryosurgical System for Bronchoscopic Applications Used in First Human Cases
Cryocision flexible cryocatheter system is the first console-free and wholly single-use flexible cryosurgical system for bronchoscopic applications available in the US and Canada.
Monitoring & Treatment
Latest
Long COVID Patients Benefit from Cognitive Therapy
Patients with long COVID receiving individualized cognitive rehab showed significantly higher goal attainment scores at three months compared to standard care.